| Literature DB >> 28846882 |
Annie M Racine1, Tamara G Fong2, Thomas G Travison3, Richard N Jones4, Yun Gou5, Sarinnapha M Vasunilashorn6, Edward R Marcantonio6, David C Alsop7, Sharon K Inouye8, Bradford C Dickerson9.
Abstract
Patients with dementia due to Alzheimer's disease (AD) have increased risk of developing delirium. This study investigated the relationship between a magnetic resonance imaging (MRI)-derived biomarker associated with preclinical AD and postoperative delirium. Participants were older adults (≥70 years) without dementia who underwent preoperative MRI and elective surgery. Delirium incidence and severity were evaluated daily during hospitalization. Cortical thickness was averaged across a published set of a priori brain regions to derive a measure known as the "AD signature." Logistic and linear regression was used, respectively, to test whether the AD signature was associated with delirium incidence in the entire sample (N = 145) or with the severity of delirium among those who developed delirium (N = 32). Thinner cortex in the AD signature did not predict incidence of delirium (odds ratio = 1.15, p = 0.38) but was associated with greater delirium severity among those who developed delirium (b = -1.2, p = 0.014). These results suggest that thinner cortices, perhaps reflecting underlying neurodegeneration due to preclinical AD, may serve as a vulnerability factor that increases severity once delirium occurs.Entities:
Keywords: Alzheimer's disease; Atrophy; Biomarker; Cortical thickness; Delirium; Delirium severity; Neurodegeneration; Preclinical Alzheimer's disease
Mesh:
Year: 2017 PMID: 28846882 PMCID: PMC5612887 DOI: 10.1016/j.neurobiolaging.2017.07.010
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673